Basic Treatment Planning

First page Previous page 600 Next page Last page

CROSS Pre-Op CRT study

Median Survival

3 yr Survival

26 months

48%

Surgery

N=363 86 SCC 273 Adenoca

ChemoRT + Surgery

49 months

59%

Made with